Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Treatment for depression in individuals with spinal cord injuries

Official title: Treatment of Depression Post-SCI: Retrospective Analysis and Feasibility Trial

Run by Medical University of South Carolina · NCT04263285 · Data updated 2026-11-12

This study is testing if a new treatment called rTMS can help people with spinal cord injuries who are also dealing with depression feel better.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment14 (estimated)
SponsorMedical University of South Carolina
Academic / other
Locations1 site (Charleston, South Carolina)
StatusRecruiting
StartedOctober 2026
Main results expectedSeptember 2029
Study endsSeptember 2029
Registry record updatedMarch 4, 2026
Trial IDNCT04263285 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 70 who are at least six months post-injury and have partial movement of the right thumb.

Probably not a fit

Patients with concomitant neurological disorders, cognitive impairments, or a history of major head trauma may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the safety and effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a treatment for depression in individuals who have experienced spinal cord injuries (SCI). Fourteen participants with cervical or thoracic level SCI and diagnosed major depressive disorder will undergo rTMS treatment five days a week for four weeks. The study aims to assess changes in depressive symptoms and the overall safety of the rTMS method. If successful, the findings could pave the way for larger studies to improve treatment options for this population.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the mental health and quality of life for individuals suffering from depression following spinal cord injuries.

How similar studies have gone: While the use of rTMS for depression is established, its application specifically for individuals with spinal cord injuries is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Age 18 - 70;
2. At least 6 months post incomplete cervical or incomplete or complete thoracic level SCI;
3. Have at least partial active movement of the right thumb (abductor pollicis brevis) to allow for FDA approved rTMS dosing;
4. Major depressive disorder, as identified through screening tools;
5. No antidepressant medications or no change in doses of psychotropic medication(s) for at least 4 weeks prior to the study (6 weeks if newly initiated medication).

Exclusion criteria:

1. Concomitant neurologic diseases/disorders or dementia;
2. Cognitive impairment, as identified through a screening tool (Montreal Cognitive Assessment);
3. History of major head trauma as identified through a screening tool (Ohio State University Traumatic Brain Injury Identification Method);
4. History of psychosis or other Axis I disorder that is primary;
5. Positive screen for bipolar disorder, as identified through a screening tool (The Mood Disorder Questionnaire);
6. Life expectancy \<1 year;
7. Attempt of suicide in the last 2 years;
8. Electronic or metallic implants (i.e. metal in the head, cochlear implant, or pacemaker);
9. History of seizures or currently prescribed anti-seizure medications;
10. Taking medication that increases the risk of seizures;
11. Pregnancy as identified through a positive pregnancy test;
12. Inability or unwillingness of subject or legal guardian/representative to give informed consent.

Where it's running

  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Catherine VanDerwerker, DPT, PhD — Medical University of South Carolina
  • Study coordinator: Catherine VanDerwerker, DPT, PhD
  • Email: vanderwe@musc.edu
  • Phone: 843-792-5047

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.